弗兰克·斯廷奇菲尔德奖:创建患者特异性全髋关节置换术后假体周围骨折风险计算器
研究纳入1998至2018年间16,696例初次非肿瘤性全髋关节置换术,平均随访6年,558例(3.3%)发生假体周围股骨骨折。基于18个患者因素中的7个独立因素构建多变量Cox回归列线图,可动态量化基于手术决策的风险改变。
要点
- 患者特异性假体周围骨折风险随合并症谱广泛变化:90天0.4-18%,1年0.4%-20%,5年0.5%-25%。
- 4个显著不可变因素:女性(HR=1.6)、年龄每增10岁(HR=1.2)、骨质疏松或用药(HR=1.7)、非骨关节炎手术指征(骨折HR=2.2,炎性关节炎HR=1.8,骨坏死HR=1.7)。
- 3个可变手术因素:非骨水泥股骨固定(HR=2.5)、无领股骨假体(HR=1.3)、非直接前入路(外侧HR=2.9,后侧HR=1.9)。
核心结论
- 该患者特异性假体周围股骨骨折风险计算器显示基于合并症谱的风险广泛变化,使外科医生能够基于手术决策量化风险缓解。
研究设计与样本
- 评估1998年至2018年间施行的16,696例初次非肿瘤性全髋关节置换术,平均随访6年,558例(3.3%)发生假体周围股骨骨折。
- 通过自然语言处理辅助的个体病历审查,对不可变因素(人口学、全髋关节置换术指征、合并症)和可变手术决策(股骨固定[骨水泥/非骨水泥]、手术入路[直接前入路、外侧、后侧]、假体类型[有领/无领])进行特征描述。
- 以术后90天、1年、5年的假体周围股骨骨折作为二分类结局,开发多变量Cox回归模型和列线图。
主要发现
- 基于合并症谱的患者特异性假体周围股骨骨折风险在90天为0.4-18%,1年为0.4%-20%,5年为0.5%-25%。
- 在评估的18个患者因素中,7个保留在多变量分析中。
- 4个显著的不可变因素包括:女性(风险比(HR)=1.6)、年龄较大(每10年HR=1.2)、骨质疏松诊断或使用骨质疏松药物(HR=1.7)、手术指征非骨关节炎(骨折HR=2.2,炎性关节炎HR=1.8,骨坏死HR=1.7)。
- 3个可变手术因素包括:非骨水泥股骨固定(HR=2.5)、无领股骨假体(HR=1.3)、非直接前入路的手术入路(外侧HR=2.9,后侧HR=1.9)。
临床怎么用
- 该患者特异性假体周围股骨骨折风险计算器使外科医生能够基于手术决策量化风险缓解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many risk factors have been described for periprosthetic femur fracture (PPFFx) following total hip arthroplasty (THA), yet a patient-specific risk assessment tool remains elusive. The purpose of this study was to develop a high-dimensional, patient-specific risk-stratification nomogram that allows dynamic risk modification based on operative decisions. METHODS: We evaluated 16,696 primary nononcologic THAs performed between 1998 and 2018. During a mean 6-year follow-up, 558 patients (3.3%) sustained a PPFFx. Patients were characterized by individual natural language processing-assisted chart review on nonmodifiable factors (demographics, THA indication, and comorbidities), and modifiable operative decisions (femoral fixation [cemented/uncemented], surgical approach [direct anterior, lateral, and posterior], and implant type [collared/collarless]). Multivariable Cox regression models and nomograms were developed with PPFFx as a binary outcome at 90 days, 1 year, and 5 years, postoperatively. RESULTS: Patient-specific PPFFx risk based on comorbid profile was wide-ranging from 0.4-18% at 90 days, 0.4%-20% at 1 year, and 0.5%-25% at 5 years. Among 18 evaluated patient factors, 7 were retained in multivariable analyses. The 4 significant nonmodifiable factors included the following: women (hazard ratio (HR) = 1.6), older age (HR = 1.2 per 10 years), diagnosis of osteoporosis or use of osteoporosis medications (HR = 1.7), and indication for surgery other than osteoarthritis (HR = 2.2 for fracture, HR = 1.8 for inflammatory arthritis, HR = 1.7 for osteonecrosis). The 3 modifiable surgical factors were included as follows: uncemented femoral fixation (HR = 2.5), collarless femoral implants (HR = 1.3), and surgical approach other than direct anterior (lateral HR = 2.9, posterior HR = 1.9). CONCLUSION: This patient-specific PPFFx risk calculator demonstrated a wide-ranging risk based on comorbid profile and enables surgeons to quantify risk mitigation based on operative decisions. LEVEL OF EVIDENCE: Level III, Prognostic.
引用
- Wyles CC, Maradit-Kremers H, Fruth KM, et al. Frank Stinchfield Award: Creation of a Patient-Specific Total Hip Arthroplasty Periprosthetic Fracture Risk Calculator. J Arthroplasty. 2023. PMID: 36933678. doi:10.1016/j.arth.2023.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。